SciSparc Secures Canadian Patent for Opioid Reduction Tech
Ticker: SPRC · Form: 6-K · Filed: Mar 8, 2024 · CIK: 1611746
| Field | Detail |
|---|---|
| Company | Scisparc Ltd. (SPRC) |
| Form Type | 6-K |
| Filed Date | Mar 8, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: patent, pharmaceuticals, pain management, intellectual property
TL;DR
SciSparc just got a Canadian patent for opioid reduction tech. Big win for pain management IP.
AI Summary
SciSparc Ltd. announced on March 6, 2024, that it was issued a Canadian patent for its opioid reduction technology in pain management. This follows a March 7, 2024, announcement regarding a patent for its core technology. The company, previously known as Therapix Biosciences Ltd., is based in Tel Aviv, Israel.
Why It Matters
The issuance of patents strengthens SciSparc's intellectual property portfolio, potentially enhancing its competitive position and future commercialization prospects in the pain management market.
Risk Assessment
Risk Level: medium — While patents are positive, the actual market impact and commercial success of the technology are yet to be determined, introducing inherent risks.
Key Players & Entities
- SciSparc Ltd. (company) — Registrant
- Therapix Biosciences Ltd. (company) — Former company name
- March 6, 2024 (date) — Date of press release
- March 7, 2024 (date) — Date of press release
FAQ
What is the specific title of the Canadian patent issued to SciSparc Ltd.?
The filing states the patent is for 'Opioids Reduction Use in Pain Management Technology'.
When did SciSparc Ltd. announce the issuance of the Canadian patent?
SciSparc Ltd. announced the issuance of the Canadian patent on March 6, 2024.
What was SciSparc Ltd.'s former company name?
SciSparc Ltd.'s former company name was Therapix Biosciences Ltd.
What is the primary business address of SciSparc Ltd.?
The primary business address is 20 Raul Wallenberg Street, Tower A, Tel Aviv, 6971916, Israel.
Does SciSparc Ltd. file annual reports under Form 20-F?
Yes, the filing indicates that SciSparc Ltd. files annual reports under Form 20-F.
Filing Stats: 427 words · 2 min read · ~1 pages · Grade level 9.3 · Accepted 2024-03-08 09:00:02
Filing Documents
- ea0201359-6k_scisparc.htm (6-K) — 14KB
- ea020135901ex99-1_scisparc.htm (EX-99.1) — 7KB
- ea020135901ex99-2_scisparc.htm (EX-99.2) — 5KB
- ea020135901ex99-3_scisparc.htm (EX-99.3) — 8KB
- 0001213900-24-020883.txt ( ) — 35KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SciSparc Ltd. Date: March 8, 2024 By: /s/ Oz Adler Name: Oz Adler Title: Chief Executive Officer and Chief Financial Officer 3